A phase 1/2 trial in pancreatic cancer, run by Sichuan Enray Pharmaceutical Sciences Company, now recruiting.
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor is a phase 1/2, interventional study registered as NCT07433283 by Sichuan Enray Pharmaceutical Sciences Company, with a registry enrolment figure of 54 participants, started 2024-11-12 and due to reach its primary completion in 2026-12-31. Interventions recorded: Carbon Nanoparticle-Loaded Iron [CNSI-Fe]; Carbon Nanoparticle-Loaded Iron. Conditions listed: Tumor, Solid; Lung Cancer; Pancreas Cancer; Thyroid Cancer; Colorectal Cancer; Cervical Cancer; Vulva Cancer. Primary outcome: Incidence and severity of participants with treatment-related adverse events as assessed by CTCAE v5.0. Pancreatic eligibility wording from the registry: "Stage Ib: patients with advanced solid tumors confirmed by histology or cytology, and the current standard therapy is ineffective (disease progression after treatment or treatment is not tolerated) or there is no effective standard treatment, such as soft tissue sarcoma, refractory thyroid cancer, c". Sites: China. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/